Stark et al. [7] demonstrated that nevi are characterized by limited mutational complexity despite harboring oncogenic BRAF or NRAS mutations, whereas progression to melanoma requires additional cooperating events affecting tumor suppressors and chromatin regulators. The gene discussed is BRAF; the disease is melanoma.